Hybio Pharmaceutical

Developer and manufacturer of polypeptide drugs and APis

placeShenzhen, Guangdong Province, China calendar_todayFounded 1998 groups975 employees language hybio.com.cn

3 investors on record; lead investors include Shenzhen Capital Group.

Investor type	Count	Share
Venture capital	2	67%
Private equity	1	33%

Coming soon